Caudill Cortney sold HALO
November 1, 2025 · Form 4 insider transaction
Caudill Cortney sold 4,263 shares of Halozyme Therapeutics, Inc. at $65.19 per share, a transaction worth $277.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 48 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,263
Price
$65.19
Total value
$277.9K
InsiderCaudill Cortney
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 1, 2025
Filing dateDecember 19, 2025
Shares owned after12,737
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported disposition of 4,263 shares represents the shares that were withheld and sold by the issuer as payment for tax withholding obligations.